In-person retrospective timeline follow-back (TLFB) interviews are a well-established method for collecting self-reports of drug use from patients. However, this method can require significant staff and patient time. In the context of a randomized clinical trial evaluating interim buprenorphine dosing, we examined the feasibility of an interactive voice response (IVR) system for daily monitoring of illicit opioid use during buprenorphine treatment, with a focus on the agreement of illicit opioid use self-report data collected from the concurrent IVR methodology versus retrospective TLFB interviews. Participants (n ϭ 24) received buprenorphine maintenance for 12 weeks and completed nightly IVR calls in which they reported illicit opioid use in the prior 24 hrs. At approximately weekly visits, they provided in-person TLFB reports of illicit opioid use. Levels of data collection were high for both IVR and TLFB methodologies (94.2% vs. 98.5%, respectively) and did not differ. Overall agreement between the 2 methods was high (97%), whereas Cohen's kappa was moderate (k ϭ 0.60). When self-report data were compared with urinalysis results for illicit opioid use, IVR and TLFB approaches both showed high specificity (ϳ99%), although sensitivity was greater for the TLFB method (48% and 69% for IVR and TLFB, respectively; p ϭ .003). These pilot data suggest that an automated IVR approach may offer an efficient alternative for monitoring self-reported opioid use, especially in rural or resource-constrained settings. Additional efforts to understand and improve IVR sensitivity are warranted.
The timeline follow-back (TLFB) is a widely used instrument for obtaining retrospective daily estimates of alcohol, cigarette, and other drug use (Sobell & Sobell, 1992) . The TLFB is typically administered using an in-person, calendar method to elicit patient reports of daily patterns and frequency of drinking behavior over a specified time period and has favorable reliability and validity (Brown et al., 1998; Hersh, Mulgrew, Van Kirk, & Kranzler, 1999; Sobell, Brown, Leo, & Sobell, 1996) . However, conducting a TLFB interview with patients can require significant staff and patient time (Sobell et al., 1996; Vakili, Sobell, Sobell, Simco, & Agrawal, 2008) . Reliance on retrospective, rather than concurrent, self-reports of drug use also raises the possibility of inaccurate or biased recall (e.g., Bardone, Krahn, Goodman, & Searles, 2000; Collins, Graham, Hansen, & Johnson, 1985; Shiffman, 2009) .
Despite the potential strengths associated with daily collection of self-reported drug use, this approach is onerous and may be impractical for use in settings where patient visits are infrequent or resources are limited. Recently there has been an increasing use of mobile health (mHealth) and automated approaches for collecting and providing clinical information on an ongoing basis (Boyer, This work was supported by the National Institute on Drug Abuse (grant R34DA037385 [to Stacey C. Sigmon], T32DA007242); and National Institute of General Medical Sciences (grant P20GM103644). The funding agencies had no further role in study design; the collection, analysis, and interpretation of data; the preparation of the manuscript; or in the decision to submit the paper for publication. Smelson, Fletcher, Ziedonis, & Picard, 2010; Helzer, Badger, Searles, Rose, & Mongeon, 2006) . One particularly promising example is phone-based interactive voice response (IVR) systems, which provide customized content and support via phone and offer advantages of low cost, consistent delivery, expanded access, 24-hr availability, privacy, and convenience (Crawford et al., 2005; Helzer et al., 2008; Kim, Bracha, & Tipnis, 2007; Moore et al., 2013; Rose et al., 2010; Stacy, Schwartz, Ershoff, & Shreve, 2009) . Patients typically use keypad or voice responses to choose among menu options, respond to prompts, and answer questions. Importantly, IVR systems are uniquely compatible with patients in resource-constrained settings, requiring no specialized equipment or extensive training. IVR hardware and software can support multiple clinic sites and have no on-site installation costs beyond telephone access. IVR systems provide broad access for lower income and marginalized populations because touch-tone phones are familiar, easy to use, do not require wireless internet, and are more widely available than computers. They use an auditory interactive process that is not hampered by low literacy. Privacy and anonymity are also greater than on a computer screen or written questionnaire because others cannot see or hear the questions or responses.
Whereas prior studies have examined the agreement of IVR and TLFB approaches for drug use, they have most often focused on tobacco and alcohol use (e.g., Carney, Tennen, Affleck, Del Boca, & Kranzler, 1998; Kranzler, Abu-Hasaballah, Tennen, Feinn, & Young, 2004; Searles, Helzer, Rose, & Badger, 2002 , Searles, Helzer, & Walter, 2000 Shiffman & Scholl, 2018; Toll, Cooney, McKee, & O'Malley, 2005; Tucker, Foushee, Black, & Roth, 2007) . Strong correlations have been reported between IVR-and TLFB-based reports of tobacco use (Toll et al., 2005) . Correlations for alcohol use have been more modest, with TLFB generally underestimating alcohol consumption relative to IVR (Searles et al., , 2002 . No studies to our knowledge have compared the two methods in the context of treatment for opioid use disorder (OUD). In this secondary analysis, the primary aim was to examine the feasibility of an IVR system for daily monitoring of illicit opioid use during buprenorphine treatment, with a focus on the agreement of illicit opioid use self-report data collected from the concurrent IVR methodology versus the retrospective TLFB interviews (Sobell & Sobell, 1992) among individuals with OUD.
Method Participants
The research design for the parent study was a randomized trial evaluating the initial efficacy of interim buprenorphine dosing over 12 weeks to reduce illicit opioid use and other risk behaviors among waitlisted adults with OUD (n ϭ 50; Sigmon et al., 2016) . Half of the sample was randomized to receive Interim Buprenorphine Treatment (IBT; n ϭ 25) and the other half to a waitlist control condition wherein participants remained on the waitlist of their local clinic (n ϭ 25).
Participants randomized to IBT visited the clinic every 2 weeks to provide urine specimens for toxicologic screening, ingest buprenorphine under nurse observation, and complete a TLFB assessment of any illicit opioid or other drug use since their last visit. The remaining doses for the 2-week interval were provided in a computerized dispenser that permitted buprenorphine administration at home. They received automated daily IVR calls each evening in which they reported any drug use via the phone keypad (e.g., "Did you use any nonprescribed opioids (such as heroin or painkillers) since yesterday's daily check-in? If no, press 0; if yes, press 1."). Any reported drug use prompted additional follow-up questions (e.g., amount, route of administration) as well as encouragement to attend support meetings in the community. The system contacted participants each evening at a predetermined time and called back every 15 min for 1 hr if they failed to answer. Participants also could make inbound calls to access clinical support at any time or to complete their daily check-in if they anticipated missing the call. IVR calls averaged 1.2 Ϯ 0.5 min in duration. IBT participants were also contacted via IVR twice monthly (generally once per 2-week dosing interval) and instructed to return to the clinic for a random call-back visit. At each random call-back, participants presented their device for inspection and pill count, ingested that day's dose under nurse observation, and provided a urine specimen. Additional study details have been previously published (Sigmon et al., 2016) .
Study Sample
The sample for this secondary analysis consisted of 25 adults with OUD randomized to receive the 12-week IBT experimental condition. As one participant had missing data for key study variables due to early withdrawal, the effective sample size for the present investigation was 24. The study protocol was reviewed and approved by the University of Vermont Institutional Review Board, and participants provided written informed consent prior to enrolling in the study.
Outcome Measures
The key response variable was illicit opioid use assessed using IVR and TLFB methods. The IVR system involved daily monitoring calls in which participants were asked questions about any illicit opioid use since the last call (i.e., past 24 hrs). The TLFB interview was administered at approximately weekly in-person clinic visits and assessed any illicit opioid use since the previous visit (i.e., past week).
Data Analysis
The primary aim of the analyses was to examine the agreement between IVR and TLFB reports of illicit opioid use. In subsequent steps, we estimated the overall agreement and adjusted for chance between IVR and TLFB over the 12-week study, which was calculated using kappa (Feinstein & Cicchetti, 1990) . Additionally, the specificity and sensitivity of IVR and TLFB were examined by comparing those self-report data to biochemical data obtained from urine toxicology. Whereas self-report data were collected for 77 days for each participant, translating to a total of 1,848 possible reporting days for the 24 participants, urinalysis data were available for approximately 300 possible reporting days (i.e., approximately 12 urine specimens collected per participant). Thus, we estimated agreement between the urinalysis results and any selfreport of illicit opioid use in the 2 days prior to collection of each urine specimen (Kilpatrick, Howlett, Sedgwick, & Ghodse, 2000) . This document is copyrighted by the American Psychological Association or one of its allied publishers.
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All statistical analyses were performed using Stata, version 14 (Stata Corp, 2015) .
Results
The majority of the sample was male, Caucasian, and primarily used heroin intravenously (n ϭ 24; Table 1 ). Participants had been on a waitlist for opioid maintenance treatment for approximately 3 months. A more detailed description of baseline characteristics has been published previously (Sigmon et al., 2016) .
Rates of data collection were high for both methodologies. Specifically, self-reports of illicit opioid use were obtained for 94.2% of reporting days by IVR (1, On 95.0% of reports in which both IVR and TLFB approaches were available (1,654/1,742), participants reported illicit opioid abstinence via both methods (see Table 2 ). On 2.2% of reporting days (39/1,742), both IVR and TLFB methods indicated recent illicit opioid use. This translates to 97.2% agreement between the two methods. In contrast, self-reports of illicit opioid use were discordant on 2.8% of reporting days (49/1,742). Of those, illicit opioid use was reported only via the IVR on 17 days (1.0%), whereas it was reported only via TLFB on 32 days (1.8%). The overall agreement between the two methods as measured by Cohen's kappa, which accounts for chance agreement, was moderate (k ϭ 0.60, 95% CI [0.55, 0.65]).
Finally, we compared IVR and TLFB methods to urine toxicology results on the subset of days for which biochemical data were available (see Table 3 ). Both methods had high specificity (99.6% [241/242; 95% CI: 97.7%, 99.9%] and 99.2% [245/247; 95% CI: 97.1%, 99.9%] for IVR and TLFB, respectively; p ϭ .99), indicating that self-reports were almost always negative on days coinciding with negative urinalysis results. In contrast, the sensitivity of IVR and TLFB methods were more moderate when illicit opioid positive urinalysis results were documented (48.2% [26/54; 95% CI: 34.6%, 61.8%]) and (68.5% [37/54; 95% CI: 56.1%, 80.7%] for IVR and TLFB, respectively; p ϭ .003).
Discussion
We examined agreement between daily self-reports of illicit opioid use collected using concurrent IVR and retrospective TLFB methodologies during outpatient buprenorphine treatment. Rates of data collection were high for both approaches. Consistent with findings from Toll et al. (2005) , slightly more complete data were obtained via TLFB interview compared with the IVR system. IVR and TLFB response rates were similar to those seen in other studies comparing the two methods (e.g., Searles et al., 2000) . The agreement between methodologies is also consistent with the association found in prior studies evaluating alcohol use as well as smoking (Brown et al., 1998; Searles et al., 2000; Shiffman et al., 2018) . To our knowledge this is the first study to do so for illicit opioid use among adults receiving buprenorphine treatment.
Although both methods were found to have favorable specificity, levels of sensitivity were more moderate and lower for IVR than TLFB. While this is an empirical question that is beyond the scope of the present study, our sense is that the increased sensitivity of the TLFB approach is likely because those data are collected at the same time as urinalysis testing, which may increase patients' self-reports of recent use if they expect that their urine results will reflect that use. If this is the case, then it is possible that patients' self-reports of use via IVR might be increased by increasing the frequency of random call-backs. There may also be merit to modifying the script they hear during the daily monitoring call to emphasize the importance of accurate self-reports. Given the potential ease and feasibility of using IVR for collecting self- Note. IVR ϭ interactive voice response; TLFB ϭ timeline follow-back. This document is copyrighted by the American Psychological Association or one of its allied publishers.
reports of drug use during treatment, additional efforts to further improve IVR sensitivity are warranted. Several limitations should be noted. The sample size in this secondary analysis was limited, although prior studies comparing IVR and TLFB have done so with comparable sample sizes (Schroder, Johnson, & Wiebe, 2007; Searles et al., 2000; Simpson, Xie, Blum, & Tucker, 2011) . Additional studies with larger samples are needed to examine the agreement between in-person and technologyassisted collection methods more definitively. Second, there were high rates of abstinence from illicit opioids during the study. Whereas this reflected a favorable outcome for the primary trial evaluating IBT (Sigmon et al., 2016) , it meant that there were low rates of positive self-reports on which to compare these methodologies. Kappa is strongly influenced by the prevalence an outcome in the sample population and can be misinterpreted when there are high levels of observed agreement and lower kappa values (Feinstein et al., 1990) .
Conclusion
The IVR system was feasible for collecting patients' selfreported use of illicit opioids during buprenorphine treatment. Automated, technology-assisted approaches may hold utility for monitoring self-reported illicit drug use among patients in treatment for OUD, especially in rural environments or resourceconstrained settings.
